Marlowe Partners’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-38,622
Closed -$7.11M 10
2020
Q4
$7.11M Sell
38,622
-30,612
-44% -$5.04M 3.81% 10
2020
Q3
$10.4M Buy
+69,234
New +$10.9M 6.06% 7

Other funds holding MSGS

Marlowe Partners's MSGS Position: Q1 2021 in Review

Marlowe Partners sold out of Madison Square Garden (MSGS) in Q1 2021, closing a stake of 38,622 shares — an estimated $7.11M sold.

Marlowe Partners first reported a position in MSGS in Q3 2020 and held it in 2 quarters. The position peaked at $10.4M in Q3 2020. 303 funds tracked by Wall St. Rank hold MSGS as of Q1 2021.

  • Marlowe Partners reported no remaining Madison Square Garden position as of Q1 2021 after selling out during the quarter.
  • Marlowe Partners sold 38,622 Madison Square Garden shares in Q1 2021, an estimated $7.11M.
  • Marlowe Partners first reported a position in Madison Square Garden in Q3 2020 and held it in 2 quarters.
  • Marlowe Partners's Madison Square Garden position peaked at $10.4M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2021.

Based on Marlowe Partners's 13F filing for Q1 2021, filed 14 May 2021.